Skip to main content
Top
Published in: BMC Public Health 1/2016

Open Access 01-12-2016 | Research article

Patterns of multimorbidity and their association with health outcomes within Yorkshire, England: baseline results from the Yorkshire Health Study

Authors: Jessica Li, Mark Green, Ben Kearns, Eleanor Holding, Christine Smith, Annette Haywood, Cindy Cooper, Mark Strong, Clare Relton

Published in: BMC Public Health | Issue 1/2016

Login to get access

Abstract

Background

Multimorbidity is increasingly being recognized as a serious public health concern. Research into its determinants, prevalence, and management is needed and as the risk of experiencing multiple chronic conditions increases over time, attention should be given to investigating the development of multimorbidity through prospective cohort design studies. Here we examine the baseline patterns of multimorbidity and their association with health outcomes for residents in Yorkshire, England using data from the Yorkshire Health Study.

Methods

Baseline data from the Yorkshire Health Study (YHS) was collected from 27,806 patients recruited between 2010 and 2012. A two-stage sampling strategy was implemented which first involved recruiting 43 general practice surgeries and then having them consent to mailing invitations to their patients to complete postal or online questionnaires. The questionnaire collected information on chronic health conditions, demographics, health-related behaviours, healthcare and medication usage, and a range of other health related variables. Descriptive statistics (chi-square and t tests) were used to examine associations between these variables and multimorbidity.

Results

In the YHS cohort, 10,332 participants (37.2 %) reported having at least two or more long-term health conditions (multimorbidity). Older age, BMI and deprivation were all positively associated with multimorbidity. Nearly half (45.7 %) of participants from the most deprived areas experienced multimorbidity. Based on the weighted sample, average health-related quality of life decreased with the number of health conditions reported; the mean EQ-5D score for participants with no conditions was 0.945 compared to 0.355 for participants with five or more. The mean number of medications used for those without multimorbidity was 1.81 (range 1-13, SD = 1.25) compared to 3.81 (range 1-14, SD = 2.44) for those with at least two long-term conditions and 7.47 (range 1-37, SD = 7.47) for those with 5+ conditions.

Conclusion

Patterns of multimorbidity within the Yorkshire Health Study support research on multimorbidity within previous observational cross-sectional studies. The YHS provides both a facility for participant recruitment to intervention trials, and a large population-based longitudinal cohort for observational research. It is planned to continue to record chronic conditions and other health related behaviours in future waves which will be useful for examining determinants and trends in chronic disease and multimorbidity.
Literature
1.
go back to reference Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10(4):430–9.CrossRefPubMed Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10(4):430–9.CrossRefPubMed
2.
go back to reference Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM. Managing patients with multimorbidity in primary care. BMJ. 2015;350:h176.CrossRefPubMed Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM. Managing patients with multimorbidity in primary care. BMJ. 2015;350:h176.CrossRefPubMed
3.
go back to reference Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.CrossRefPubMed Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.CrossRefPubMed
4.
go back to reference Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011;61(582):e12–21.CrossRefPubMed Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011;61(582):e12–21.CrossRefPubMed
5.
go back to reference France EF, Wyke S, Gunn JM, Mair FS, McLean G, Mercer SW. Multimorbidity in primary care: a systematic review of prospective cohort studies. Br J Gen Pract. 2012;62(597):e297–307.CrossRefPubMedPubMedCentral France EF, Wyke S, Gunn JM, Mair FS, McLean G, Mercer SW. Multimorbidity in primary care: a systematic review of prospective cohort studies. Br J Gen Pract. 2012;62(597):e297–307.CrossRefPubMedPubMedCentral
6.
go back to reference Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004;2:51.CrossRefPubMedPubMedCentral Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004;2:51.CrossRefPubMedPubMedCentral
7.
go back to reference Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A: Long-term conditions and mental health: the cost of co-morbidities. London: The King's Fund; 2012. Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A: Long-term conditions and mental health: the cost of co-morbidities. London: The King's Fund; 2012.
8.
go back to reference Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357–63.CrossRefPubMedPubMedCentral Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357–63.CrossRefPubMedPubMedCentral
9.
go back to reference Mercer SW, Smith SM, Wyke S, O'Dowd T, Watt GC. Multimorbidity in primary care: developing the research agenda. Fam Pract. 2009;26(2):79–80.CrossRefPubMed Mercer SW, Smith SM, Wyke S, O'Dowd T, Watt GC. Multimorbidity in primary care: developing the research agenda. Fam Pract. 2009;26(2):79–80.CrossRefPubMed
10.
go back to reference Smith SM, Soubhi H, Fortin M, Hudon C, O'Dowd T. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev. 2012;4:CD006560. Smith SM, Soubhi H, Fortin M, Hudon C, O'Dowd T. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev. 2012;4:CD006560.
11.
go back to reference Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, Glynn L, Muth C, Valderas JM. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9(7), e102149.CrossRefPubMedPubMedCentral Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, Glynn L, Muth C, Valderas JM. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9(7), e102149.CrossRefPubMedPubMedCentral
12.
go back to reference van den Akker M, Buntinx F, Knottnerus JA. Comorbidity or multimorbidity. Eur J Gen Pract. 1996;2(2):65–70.CrossRef van den Akker M, Buntinx F, Knottnerus JA. Comorbidity or multimorbidity. Eur J Gen Pract. 1996;2(2):65–70.CrossRef
13.
go back to reference van den Akker M, Buntinx F, Roos S, Knottnerus JA. Problems in determining occurrence rates of multimorbidity. J Clin Epidemiol. 2001;54(7):675–9.CrossRefPubMed van den Akker M, Buntinx F, Roos S, Knottnerus JA. Problems in determining occurrence rates of multimorbidity. J Clin Epidemiol. 2001;54(7):675–9.CrossRefPubMed
14.
go back to reference Mercer SW, Gunn J, Wyke S: Improving the health of people with multimorbidity: the need for prospective cohort studies. Journal of Comorbidity. 2011;1(1):4. Mercer SW, Gunn J, Wyke S: Improving the health of people with multimorbidity: the need for prospective cohort studies. Journal of Comorbidity. 2011;1(1):4.
15.
16.
go back to reference Department of Health: Health Weight, Healthy Lives: A Cross-Government Research and Surveillance Plan. In. London: Department of Health; 2008. Department of Health: Health Weight, Healthy Lives: A Cross-Government Research and Surveillance Plan. In. London: Department of Health; 2008.
17.
go back to reference Green MA, Li J, Relton C, Strong M, Kearns B, Wu M, Bissell P, Blackburn J, Cooper C, Goyder E, et al. Cohort profile: The Yorkshire Health Study. Int J Epidemiol. 2014. Green MA, Li J, Relton C, Strong M, Kearns B, Wu M, Bissell P, Blackburn J, Cooper C, Goyder E, et al. Cohort profile: The Yorkshire Health Study. Int J Epidemiol. 2014.
18.
go back to reference Relton C, Bissell P, Smith C, Blackburn J, Cooper CL, Nicholl J, Tod A, Copeland R, Loban A, Chater T, et al. South Yorkshire Cohort: a ‘cohort trials facility’ study of health and weight - protocol for the recruitment phase. BMC Public Health. 2011;11:640.CrossRefPubMedPubMedCentral Relton C, Bissell P, Smith C, Blackburn J, Cooper CL, Nicholl J, Tod A, Copeland R, Loban A, Chater T, et al. South Yorkshire Cohort: a ‘cohort trials facility’ study of health and weight - protocol for the recruitment phase. BMC Public Health. 2011;11:640.CrossRefPubMedPubMedCentral
19.
go back to reference Relton C, Torgerson D, O’Cathain A, Nicholl J: Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design. BMJ. 2010; 340:c1066. Relton C, Torgerson D, O’Cathain A, Nicholl J: Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design. BMJ. 2010; 340:c1066.
21.
go back to reference Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–43.CrossRefPubMed Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–43.CrossRefPubMed
22.
go back to reference Relton C, Li J, Strong M, Holdsworth M, Cooper R, Green M, Bissell P. Deprivation, clubs and drugs: results of a UK regional population-based cross-sectional study of weight management strategies. BMC Public Health. 2014;14:444.CrossRefPubMedPubMedCentral Relton C, Li J, Strong M, Holdsworth M, Cooper R, Green M, Bissell P. Deprivation, clubs and drugs: results of a UK regional population-based cross-sectional study of weight management strategies. BMC Public Health. 2014;14:444.CrossRefPubMedPubMedCentral
23.
go back to reference Huntley AL, Johnson R, Purdy S, Valderas JM, Salisbury C. Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide. Ann Fam Med. 2012;10(2):134–41.CrossRefPubMedPubMedCentral Huntley AL, Johnson R, Purdy S, Valderas JM, Salisbury C. Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide. Ann Fam Med. 2012;10(2):134–41.CrossRefPubMedPubMedCentral
24.
go back to reference Macleod U, Mitchell E, Black M, Spence G. Comorbidity and socioeconomic deprivation: an observational study of the prevalence of comorbidity in general practice. Eur J Gen Pract. 2004;10(1):24–6.CrossRefPubMed Macleod U, Mitchell E, Black M, Spence G. Comorbidity and socioeconomic deprivation: an observational study of the prevalence of comorbidity in general practice. Eur J Gen Pract. 2004;10(1):24–6.CrossRefPubMed
25.
go back to reference Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA. Multimorbidity prevalence and patterns across socioeconomic determinants: a cross-sectional survey. BMC Public Health. 2012;12:201.CrossRefPubMedPubMedCentral Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA. Multimorbidity prevalence and patterns across socioeconomic determinants: a cross-sectional survey. BMC Public Health. 2012;12:201.CrossRefPubMedPubMedCentral
27.
go back to reference Agborsangaya CB, Majumdar SR, Sharma AM, Gregg EW, Padwal RS. Multimorbidity in a prospective cohort: prevalence and associations with weight loss and health status in severely obese patients. Obesity. 2015;23(3):707–12.CrossRefPubMed Agborsangaya CB, Majumdar SR, Sharma AM, Gregg EW, Padwal RS. Multimorbidity in a prospective cohort: prevalence and associations with weight loss and health status in severely obese patients. Obesity. 2015;23(3):707–12.CrossRefPubMed
31.
go back to reference Kearns B, Ara R, Young T, Relton C. Association between body mass index and health-related quality of life, and the impact of self-reported long-term conditions - cross-sectional study from the south Yorkshire cohort dataset. BMC Public Health. 2013;13:1009.CrossRefPubMed Kearns B, Ara R, Young T, Relton C. Association between body mass index and health-related quality of life, and the impact of self-reported long-term conditions - cross-sectional study from the south Yorkshire cohort dataset. BMC Public Health. 2013;13:1009.CrossRefPubMed
Metadata
Title
Patterns of multimorbidity and their association with health outcomes within Yorkshire, England: baseline results from the Yorkshire Health Study
Authors
Jessica Li
Mark Green
Ben Kearns
Eleanor Holding
Christine Smith
Annette Haywood
Cindy Cooper
Mark Strong
Clare Relton
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2016
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-016-3335-z

Other articles of this Issue 1/2016

BMC Public Health 1/2016 Go to the issue